Skip to content

Comparison of Pelvimetric Measurements Between MRI and Low-dose Stereoradiography (EOS® Imaging System)

Comparison of Pelvimetric Measurements Between MRI and Low-dose Stereoradiography (EOS® Imaging System)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04849975
Acronym
CAPEOS®
Enrollment
35
Registered
2021-04-20
Start date
2021-11-09
Completion date
2023-07-24
Last updated
2023-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breech Fetal Presentation

Keywords

Breech Fetal Presentation, MRI, EOS imaging system, Pelvimetric measurements

Brief summary

The main objective of this study is to compare pelvimetric measurements performed by Magnetic Resonance Imaging (MRI) and by the EOS imaging system.

Detailed description

During pregnancy, after failure of External Manual Version (EMV) in case of breech fetal presentation, a radiological pelvimetry is performed to evaluate the measurements of the pelvis and decide on the appropriate mode of delivery. Several imaging modalities are used, including pelvic computed tomography (CT),and magnetic resonance imaging (MRI) of the pelvis. CT scan has the disadvantage of maternal irradiation and MRI has the disadvantage of an inaccurate morphological analysis.The EOS® system is an imaging tool used in radiopediatric to allow precise morphological analysis of bone masses with minimal irradiation. The quality of the morphological analysis and measurements provided by the EOS® imaging system is the reason for proposing this study comparing the pelvimetric measurements obtained by MRI and by the EOS® imaging system.

Interventions

OTHERPelvimetric measurements

The patients in this group are pregnant women after failure of external manual version (EMV) in case of breech fetal presentation. The participants will successively perform MRI pelvimetry (conventional management) and EOS imaging.

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients \> 18 years of age * Patient requiring pelvimetry (breech fetus) * Gestation \> 36 SA (weeks of amenorrhea) * Patients with BMI \< 35 * Affiliated to social security or similarly regime * Patients who gave their consent to participate in the study (Patient having agreed to perform both examinations: MRI and EOS system)

Exclusion criteria

* Patient with a contraindication to MRI (claustrophobia, pace-maker, intracorporeal metallic element) * Patient with a contraindication to performing EOS® (person not standing alone) * Patient who are in exlusion period of another interventiionnal study * Person deprived of freedom by judicial or administrative decision; person hospitalized for psychitric care; person under legal protection measure.

Design outcomes

Primary

MeasureTime frameDescription
Estimation of the reliability of pelvimetric measurements using Transverse Inlet Diameter measurementUp to 1 dayTransverse Inlet Diameter Measurement obtained by EOS® system versus MRI is evaluated in millimeters.
Estimation of the reliability of pelvimetric measurements using ante posterior diameter measurementUp to 1 dayAnte posterior diameter of the pelvic inlet obtained by using EOS® system versus MRI is evaluated in millimeters.
Estimation of the reliability of pelvimetric measurements using BiSpinous Diameter measurementUp to 1 dayBiSpinous Diameter obtained by EOS® system versus MRI is evaluated in millimeters.
Estimation of the reliability of pelvimetric measurements using Bi-ischiatic mesurementUp to 1 dayBi-ischiatic measurement obtained by EOS® system versus MRI is evaluated in millimeters.
Estimation of the reliability of pelvimetric measurements using Magin's Index calculationUp to 1 dayMagnin's Index calculation obtained by using EOS® system versus MRI is evaluated in millimeters.

Secondary

MeasureTime frameDescription
Pelvis morphological description using obturating holes appearanceUp to 1 dayThe appearance of the obturating holes (descriptive analysis) obtained by MRI and EOS® system is qualified.
Evaluation of the intra and inter-observer reproducibility for clinical interpretation4 daysBlind independent reading of MRI and EOS® images by two independent clinician on two different days with conclusion on the mode of delivery.
Characterization of radiation doses received by EOS® system.Up to 1 dayEstimation of irradiation
Pelvis morphological description using Cadwell and Moloy classificationUp to 1 dayCaldwell and Moloy classification (scale) obtained by MRI and EOS® system is qualified.
Pelvis morphological description using subpubic angle measurementUp to 1 dayThe measurement of the subpubic angle (in degree) obtained by MRI and EOS® system is qualified.
Evaluation of the intra and inter-observer reproducibility for radiological interpretation4 daysBlind independent reading of MRI and EOS® images by two radiologists on two different days.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026